Price data is not available
OKYO Pharma Ltd
OKYONASDAQ
OKYO Pharma fell 45.4% from $2.60 to $1.42, behind the S&P 500's +11.2%. Its worst day was Feb 13 (−19.4%), and its low came Nov 9 at $1.28.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
OKYO Pharma shares rose 17.2%, while the S&P 500 rose 0.1%.
+17.2% · S&P 500 +0.1%
OKYO Pharma closed at its highest level of the year, 19.6% above where the year started.
+8.0% · S&P 500 −0.2%
Story events cover the past 12 months · Times ET
OKYO Pharma shares rose 13.9%, while the S&P 500 rose 0.5%.
+13.9% · S&P 500 +0.5%
EPS of $-0.07 was reported on $0.00 revenue.
+2.0% · S&P 500 +0.5%
OKYO Pharma shares fell 19.4%, while the S&P 500 rose 0.1%.
−19.4%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 +0.1%
EPS of $-0.24 missed the $-0.13 estimate on $0.00 revenue.
−4.2% · S&P 500 −0.2%
OKYO Pharma shares rose 12.4%, while the S&P 500 rose 0.5%.
+12.4% · S&P 500 +0.5%
Where it ended: a close of $1.42 on Nov 11, 2026. Up next: H1 2027 earnings on Jan 29, 2027 (EPS est. $-0.03).
Nothing in the past 12 months.
All OKYO dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OKYO and SPY from Benzinga historical bars. Not investment advice.
